m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer

MLA

Zi-Hao Feng, et al. “M6A-Immune-Related LncRNA Prognostic Signature for Predicting Immune Landscape and Prognosis of Bladder Cancer.” Journal of Translational Medicine, vol. 20, no. 1, Oct. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12967-022-03711-1.

APA

Zi-Hao Feng, Yan-Ping Liang, Jun-Jie Cen, Hao-Hua Yao, Hai-Shan Lin, Jia-Ying Li, Hui Liang, Zhu Wang, Qiong Deng, Jia-Zheng Cao, Yong Huang, Jin-Huan Wei, Jun-Hang Luo, Wei Chen, & Zhen-Hua Chen. (2022). m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer. Journal of Translational Medicine, 20(1), 1–11. https://doi.org/10.1186/s12967-022-03711-1

Chicago

Zi-Hao Feng, Yan-Ping Liang, Jun-Jie Cen, Hao-Hua Yao, Hai-Shan Lin, Jia-Ying Li, Hui Liang, et al. 2022. “M6A-Immune-Related LncRNA Prognostic Signature for Predicting Immune Landscape and Prognosis of Bladder Cancer.” Journal of Translational Medicine 20 (1): 1–11. doi:10.1186/s12967-022-03711-1.